Changes in QoL and Symptoms in Patients With Polycythemia Vera Receiving Ruxo in a Routine Clinical Practice (QoL-PV-R)

Multinational Center for Quality of Life Research, Russia

Status: Not yet enrolling

Conditions: Polycythemia Vera

Treatments: Drug: Ruxolitinib

Study type: Observational

Funder types: Other

Identifiers

NCT05566535

CINC424BRU04T

Details and patient eligibility

About

The purpose of this multicenter observational prospective cohort study is to examine changes in QoL and symptoms in patients with polycythemia vera (PV) during treatment with ruxolitinib (Ruxo), and to evaluate efficacy and safety of Ruxo in a real-world setting

Enrollment: 32 estimated patients

Sex: All

Ages: 18+ years old

Volunteers: No Healthy Volunteers

Inclusion criteria

• Patients who have confirmed diagnosis of PV
• Patients whose age - 18 years and older
• Patients who signed informed consent
• Patients who able to fill out questionnaires

Exclusion criteria

• Patients enrolled in clinical trials
• Patients with contraindications to Ruxo in accordance with instruction for use